Tirzepatide – 10-30mg Injection | Dual GLP-1 & GIP Receptor Agonist for Advanced Weight and Metabolic Management

---

Peptide Calculator

---

Description:

Tirzepatide is a next-generation peptide that activates both GLP-1 and GIP receptors to promote effective weight loss, appetite control, and improved blood sugar regulation. Its dual-action makes it a cutting-edge tool in metabolic health and body recomposition protocols.

---

Key Benefits:

• Provides strong appetite suppression and reduced caloric intake

• Enhances fat loss while preserving lean muscle

• Improves insulin sensitivity and glycemic control

• Supports metabolic balance during cutting or weight management

• Administered via subcutaneous injection for efficient absorption

---

How It Works:

By activating both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, Tirzepatide regulates appetite, slows gastric emptying, and improves insulin secretion. This dual effect supports sustained weight loss and better blood sugar control.

---

Suggested Use:

Strength: 10-30mg per vial (multi-dose)
Typical Dose: Starting dose of 2.5mg once weekly, gradually increasing as tolerated (up to 15mg weekly or as prescribed)
Administration: Subcutaneous injection, typically once per week
Cycle Application: Primarily used for metabolic health, weight loss, and body composition support
Notes: Requires careful dose escalation

---

Product Specifications:

Strength: 10-30mg per vial
Volume: Multi-dose vial designed for weekly dosing
Storage: Store refrigerated between 2–8°C (36–46°F); protect from light